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1. INTRODUCTION
Arsenic (As) and fluoride (F) are potent toxicants, 
widely distributed through drinking water and food 
and often result in adverse health effects. Millions of 
people are currently at risk all over the world because 
they drink water containing carcinogenic amounts of As 
and F. Permissible limit of As in water is 10 µg/l and for 
F it is 1 mg/l as per WHO guidelines1. The occurrence of 
As and F in groundwater has been widely reported in 
Latin America, especially in arid and semi-arid regions of 
Mexico, Argentina, and Chile2. Few reports also suggest the 
coexistence of the two toxicants in other areas of the world 
including, India3. The interaction of As with F could be a key 
in the complete elucidation of the molecular mechanisms 
involved in the development of inflammatory and malignant diseases4. Zhang5, et al. suggested that the toxicological 
effects of fluoride could be enhanced by arsenic while, 
contradictory results suggesting independent, synergistic 
and antagonistic effects in different animal models too have 
been reported6-10. It has been also suggested that arsenic–
fluoride interaction during co-exposure induces oxidative 
stress and DNA damage11-13. The potential role of oxidative 
stress in the cell injury associated with arsenic and fluoride 
poisoning suggests that antioxidants can be employed in 
the treatment protocols to mitigate arsenic- and fluoride 
induced toxicity. Vitamin E10, melatonin14 and curcumin15 
supplementation during co-exposure has been found to 
be beneficial in restoring altered biochemical variables, 
maintaining pro-oxidant/antioxidant balance, and reducing 
genotoxicity as well as body arsenic and fluoride levels.
Among other strategies emerging to counteract metal 
toxicity is site-specific targeted delivery of drugs using 
appropriate carriers such as liposomes, micelles and 
nanoparticles. Nanoparticles due to its ability to evade 
reticuloendothelial system (RES) such as liver Kupffer cells 
and spleen macrophages can be delivered to the desired 
site effectively. Another advantage of using nanoparticles 
for drug delivery is its potential to cross blood-brain 
barrier; which further enhances its specific delivery. We 
have recently reported a novel strategy using encapsulated 
curcumin nanoparticles to counteract arsenic toxicity16. Our 
hypothesis was based on the fact that nanoencapsulation of 
curcumin would result in increasing its bioavailability and 
thus would be an interesting strategy to reduce the dose 
required for a desired effect against metal toxicity. More 
recently, nanocurcumin synthesised and characterised by 
our group have been shown to be effective against lead 
induced oxidative stress17.
In continuation of our efforts to design an effective 
strategy for metal toxicity, the present study was planned 
to assess the preventive effects of nanocurcumin on toxic 
effects of arsenic and fluoride individually, and during co-
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exposure on biochemical variables suggestive of alterations 
in hematopoietic, hepatic and renal oxidative stress, and 
arsenic and fluoride concentration in blood.
2. METHODS
2.1 Chemicals and Reagents
 Curcumin, chitosan (molecular weight 400 kDa), 
and sodium meta-arsenite (NaAsO2) were purchased from 
Sigma-Aldrich (St. Louis, MO, uSA). All other chemicals 
and reagents used were of analytical grade and purchased 
from Sigma-Aldrich, Merck (Darmstadt, Germany) or BDH 
Chemicals (Bengaluru, India). Triple-distilled water was 
prepared using a Millipore (Billerica, MA, uSA) water 
purification system and was used throughout the study.
2.2 Synthesis and Characterisation of 
Encapsulated Curcumin Nanoparticles
Nanocurcumin were synthesised and characterised as 
reported previously16. Briefly, Tween 80 (0.5 ml) was added 
to 20 ml of a 0.15% solution of chitosan in dilute acetic 
acid (35 mM) with constant stirring for 1 hour. Then 250 
µl of curcumin solution (10 or 20 mg/ml in chloroform) 
was added in aliquots of ~ 20 µl with stirring. The solution 
was stirred for a further 1 hour, after which 0.5 ml of 20% 
sodium sulfate solution was added drop wise with stirring 
and stirring was continued for another 30 minutes. To 
crosslink the nanoparticles, 0.1 ml of glutaraldehyde was 
added to the solution and stirring continued for another 
30 minutes. Finally, 1 ml of 10% sodium metabisulfite was 
added to the solution and stirred for another 30 minutes. 
The solution was left to stand for 12 hours and was then 
dialysed against water with two changes at 4 °C for 24 
hours, and then against normal saline with two changes at 
4 °C for 24 hours. The dialysed solution was preserved at 
4 °C for characterisation and efficacy studies. The solution 
was lyophilised to yield a thick, viscous liquid. The size 
and morphology of the nanoparticles were determined by 
transmission electron microscopy (TEM) using a JEOL JEM 
2000EX200 electron microscope.
2.3 Efficacy of Nanocurcumin: Animal exposure
An experiment was designed to evaluate the preventive 
efficacy which included the antioxidant and metal chelating 
property of nanocurcumin when administered by oral 
route against chronic arsenic and fluoride exposure in male 
Wistar rats.
Animals were obtained from the animal house facility 
of the Defense Research and Development Establishment 
(DRDE), Gwalior. The animal ethics committee of DRDE 
approved the experimental protocol. Experiments were 
performed on male Wistar rats (150±15 g), housed in 
stainless steel cages in an air-conditioned room maintained 
at 25±2°C and 12 hour light: 12 hour dark cycles. The 
animals were acclimatised for 7 days prior to their use in 
experiments and were allowed a standard diet and water 
throughout the study.
The rats were divided into seven groups of six rats 
each so that the group mean and standard deviation in body 
weight were approximately equal. Animals were treated for 
4 weeks according to the following protocols:
Group 1: normal (no treatment)
Group 2: arsenic (sodium arsenite, 2 mg/kg orally for 4 
weeks)
Group 3:  fluoride (50 ppm in drinking water for 4 weeks)
Group 4: arsenic + fluoride (same as in group 2 and 3)
Group 5: arsenic + nanocurcumin (15 mg/kg orally for 4 
weeks)
Group 6: fluoride + nanocurcumin (15 mg/kg orally for 4 
weeks)
Group 7: arsenic + fluoride + nanocurcumin (15 mg/kg 
orally for 4 weeks)
Group 8: nanocurcumin (15 mg/kg orally for 4 weeks)
The dose for nanocurcumin was chosen based on our 
previously reported study16-17. For simplicity purposes 
in the experiment we have not kept the bulk curcumin 
group. After 4 weeks, rats were anesthetised under light 
ether and blood samples were collected using a needle via 
intra-cardiac puncture. The animals were sacrificed and 
samples of brain and liver were collected for biochemical 
and arsenic analyses.
2.4 Biochemical Analysis
2.4.1 ROs assay
ROS levels in blood, brain and liver were measured 
using 2′,7′-dichlrofluorescein diacetate (DCFDA), which is 
converted to highly fluorescent DCF by cellular peroxides 
(including hydrogen peroxide). The assay was performed 
as described by Socci18, et al. In brief, 5% RBC hemolysate 
and 1% brain and 1% liver homogenates were prepared 
in ice-cold 40 mM Tris–HCl buffer (pH 7.4). Samples were 
further diluted to 0.25% with the same buffer and placed 
on ice. Each sample was divided into two equal fractions 
(2 ml each). To one fraction, 40 µl of 1.25 mM DCFDA in 
methanol was added for ROS estimation. The same volume 
of methanol was added to the other fraction as a control 
for sample auto fluorescence. All samples were incubated 
for 15 minutes in a 37°C water bath. The fluorescence was 
determined at 488 nm excitation and 525 nm emission using 
a Perkin-Elmer (uK) LS-55 fluorimeter. Blood, brain and 
liver ROS readings are expressed as arbitrary fluorescence 
intensity units (FIu at 530 nm).
2.4.2 Glutathione (Gsh) assays
Blood GSH concentrations were assayed using a slight 
modification of a literature method.19 Approximately 0.2 
ml of whole blood was added to 1.8 ml of distilled water 
and incubated for 10 min at 37 °C for complete hemolysis. 
After adding 3 ml of 4% sulfosalicylic acid, the tube was 
centrifuged at 2500 rpm for 15 minutes. To the supernatant, 
0.2 ml of 10 mM 5,5′dithiobis-(2 nitrobenzoic acid) was 
added in the presence of phosphate buffer (0.1 M, pH 7.4). 
The absorbance at 412 nm was used to calculate the GSH 
concentration.
Brain and liver GSH and GSSG were estimated as 
previously described20. In brief, 0.25 g of tissue sample was 
homogenised on ice with 3.75 ml of 0.1 M phosphate–0.005 
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M EDTA buffer (pH 8.0) and 1 ml of 25% HPO3 as a protein 
precipitant. The homogenate (4.7 ml) was centrifuged at 
100,000g for 30 minutes at 4oC. For the GSH assay, 0.5 ml of 
supernatant and 4.5 ml of phosphate buffer (pH 8.0) were 
mixed. The final assay mixture (2.0 ml) contained 100 µl 
of supernatant, 1.8 ml of phosphate–EDTA buffer and 
100 µl of o-phthalaldehyde (OPT; 1000 µl/ml in absolute 
methanol, prepared fresh). After mixing, the fluorescence 
was determined at 420 nm with an excitation wavelength 
of 350 nm using a Perkin-Elmer LS-55 fluorimeter.
For the GSSG assay, 0.5 ml of supernatant was 
incubated at room temperature with 200 µl of 0.04 M 
N-ethylmaleimide for 30 min. To this mixture, 4.3 ml of 
0.1 M NaOH was added. An aliquot of 100µl of this mixture 
was used to measure GSSG according to the procedure 
described above for GSH, except that 0.1 M NaOH was used 
as the diluent instead of phosphate buffer.
2.4.3  Blood δ-aminolevulinic acid Dehydratase 
(δ-alaD) activity
Blood δ-ALAD was assayed according to the method of 
Berlin and Schaller21. The assay system consisted of 0.2 ml 
of heparinised blood and 1.3 ml of distilled water. After 10 
minutes of incubation at 37 °C for complete hemolysis, 1 
ml of standard δ-ALA was added to the tube and incubated 
for 60 minutes at 37 °C, when the reaction was stopped 
by adding 1 ml of trichloroacetic acid. An equal volume of 
Ehrlich’s reagent was added to the supernatant and the 
absorbance was measured at 555 nm after 5 min.
2.4.4  Glutathione peroxidase (GPx) activity
Glutathione peroxidase enzyme is an enzyme containing 
four selenium-cofactors that catalyzes the breakdown 
of hydrogen peroxide and organic hydroperoxides. 
Glutathione peroxidase activity was measured by the 
literature procedure22. The activity of GPx was determined 
by quantifying the rate of H2O2-induced oxidation of 
reduced glutathione (GSH) to oxidised glutathione (GSSH). 
A yellow product, which had absorbance at 412 nm, could 
be formed as GSH reacted with dithiobisnitrobenzoic acid. 
The reaction involved measure of the reduced GSH. 5,5’- 
dithiobis-2-nitrobenzoic acid is reduced by free –SH groups 
of glutathione to form 1 molecule of 5-thio-2-nitrobenzoic 
acid per molecule of –SH. The nitromercaptobenzoic acid 
anion released has an intense yellow color and can be used 
to measure –SH groups. 
Briefly, supernatant obtained after centrifuging 5% 
tissue homogenate at 1500×g for 10 minutes followed by 
10,000×g for 30 minutes at 4 °C was used for GPx assay. 
1 ml of reaction mixture was added to 0.3 ml of tissue 
homogenate supernatant. After incubation at 37 °C for 15 
minutes, reaction was terminated by addition of 0.5 ml 
TCA. Tubes were centrifuged at 1500×g for 5 minutes and 
supernatant was collected. 0.2 ml of phosphate buffer (0.1M 
pH 7.4) and 0.7 ml of DTNB was added to 0.1 ml of reaction 
supernatant. After mixing, absorbance was recorded at 
420 nm. The activity of enzyme was expressed as µg of GSH 
consumed/min/mg protein.
2.4.5  Glutathione-s-transferase (GsT) activity
GST activity was determined following the literature 
procedure23. The GST activity is determined by measuring 
the rate of formation of conjugate of GSH and 1-chloro-2, 
4-dinitrobenzene (CDNB), which in turn is determined 
spectrophotometrically by recording increase in absorbance 
at 340 nm.
Briefly, reaction mixture contained 0.02 ml of 1-chloro 
2, 4-dinitro benzene and 2.9 ml of GSH and 30 µl of post 
mitochondrial supernatant and change in color were 
monitored by recording absorbance (340 nm) at 30 
sec intervals for 3 minutes. The activity of enzyme was 
expressed as nmoles of GSH-CDNB conjugate formed/
min/mg protein, using molar extinction coefficient of the 
conjugate (9.6 x 106 M-1cm-1).
2.4.6  Thiobarbituric acid Reactive substances assay
Thiobarbituric acid reactive substances (TBARS) were 
measured according to a method reported in literature24 by 
incubating whole-tissue homogenate with 8.1% SDS (w/v) 
for 10 minutes, followed by addition of 20% acetic acid (pH 
3.5)23. The reaction mixture was further incubated with 
0.6% TBA (w/v) for 1 hour in a boiling water bath. The pink 
chromogen that formed was extracted in butanol pyridine 
solution and the absorbance was measured at 532 nm. The 
amount of TBARS was calculated using a molar extinction 
coefficient of 1.56×105 M/cm.
2.5 Liver and Kidney Function Tests
GOT and GPT as liver function test (LFT) and urea 
and creatinine as kidney function test (KFT) were done by 
an automatic clinical analyser (Erba Mannheim, EM200) 
according to the manufacturer’s protocol. Reagents for the 
assays were provided by the same manufacturer.
2.6  Urinary 8-OHdG levels
8-hydroxy-2′-deoxyguanosine (8-OHdG) levels in 
urine were measured using commercial kits (8-OHdG, 
highly sensitive 8-OHdG check kit, JAICA, Fukuroi, Japan) 
by the protocol provided by the manufacturer.
2.6 Arsenic and Fluoride Estimation in Blood
As concentration in blood was measured following 
wet acid digestion using a microwave digestion system 
(Anton Paar Multiwave 3000, Austria, Europe). Samples 
were brought to a constant volume, and determination 
was performed using an auto sampler (As-72) and 
graphite furnace (MHS) fitted with an atomic absorption 
spectrophotometer (AAS, Perkin-Elmer model AAnalyst 
100). A calibration curve was constructed by adding known 
amounts of arsenic standard (TraceCERT®, 1000 mg/L As 
in nitric acid, Sigma-Aldrich) to calculate arsenic levels.
F concentration was measured in the digested blood 
and tissue samples using Orion ion analyser (Orion, Seattle, 
WA, uSA) as reported previously9. Briefly, by constructing 
the cell using the fluoride ion-selective electrode and 
calomel reference electrode in a solution of fluoride at pH 
5.35 adjusted with total ionic strength adjusting buffer 
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(TISAB), the cell potential was determined. By measuring 
the cell potential for a series of fluoride standards like 
0.1, 1.0, 10.0, 100, and 1000 mg/L and constructing the 
standard calibration graph by plotting the cell potential 
versus log(F), it is possible to find out the unknown fluoride 
concentration from measured cell potential. The detection 
limit of the instrument was 0.025 mg/L to 500 mg/L.
2.7 Statistical Analysis
 Results are expressed as mean ± SEM for the number 
of observations indicated. Mean values were compared 
using one-way analysis of variance (ANOVA) followed by 
Bonferroni’s test to compare means between the different 
treatment groups. Differences were considered significant 
at p< 0.05 unless otherwise stated.
3. RESULTS
3.1 Nanocurcumin Synthesis and Characterisation
Curcumin was encapsulated in chitosan nanoparticles 
cross-linked with glutaraldehyde as reported previously16. 
The size and size distribution of the nanoparticles 
demonstrated the particles have spherical morphology and 
low polydispersity, with an approximate size of ~ 50 nm 
(Fig. 1). 
nanocurcumin treatment significantly showed protection 
in all the altered blood biochemical variables compared to 
the exposed animals.
Figure 1. Size characterisation of the nanoparticles using 
transmission electron micrograph studies.
3.2 Body Weight Changes
Effect of exposure to arsenic, fluoride and nanocurcumin 
either individually or in combination on body weight gain 
in rats is shown in Table 1. The difference in body weight at 
the end of exposure was not statistically different compared 
to control animals.
3.3 Oxidative Stress Parameters in Blood
Figure 2 indicates toxic effects of arsenic and fluoride 
on some blood biochemical variables followed by significant 
protection with nanocurcumin. Individual and combined 
exposure to arsenic and fluoride significantly induced 
the elevated level of ROS followed by depleted GSH level 
suggestive of oxidative stress. δ-ALAD activity also found to 
be inhibited in the groups exposed with arsenic alone or in 
combination with fluoride. On the other hand, concomitant 
Table 1. Individual and combined effect of As, F and NC on 
body weight gain in rats
Treatment Body Weight Gain (g)
Control 87.0±5.6As 88.8±2.2
F 100.4±3.4
As + F 81.0±4.9
As + NC 81.6±1.9
F + NC 82.4±4.2
As + F + NC 69.0±4.0
NC 70.2±4.2
Abbreviations used and units: Body weight in grams. Values are mean ± 
SEM; (n = 5). 
Differences between values with matching symbol notations within each 
row are not statistically significant at a 5% level of probability.
Figure 2. Effect of nanocurcumin supplementation on arsenic and 
fluoride induced altered blood biochemical variables 
in rats. Values are mean ± SEM, n = 5. Values with 
the same symbol within each bar are not significantly 
different at the 5% level of probability.
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3.4 Hepatic and Renal Oxidative Stress Variables 
Figure 3 and 4 show protective efficacy of 
nanocurcumin on altered tissue ROS, GSH, TBARS, GPx and 
GST levels induced by individual and combined exposure 
to arsenic and fluoride and its concomitant treatment 
with nanocurcumin. The graph shows that exposure to 
arsenic and fluoride led to a significant increase in ROS 
level whether given alone or in combination. On the other 
hand, exposure to arsenic and fluoride reduced the levels of 
GSH in both the tissues of rats. TBARS level was found to be 
increased significantly on exposure to arsenic and fluoride 
alone and in combination. Exposure to arsenic and fluoride 
also altered levels of glutathione linked enzymes, GPx and 
GST. GPx and GST activities were reduced in both liver 
and kidney when given alone or in combination. Whereas, 
nanocurcumin co-treatment significantly protects the 
Figure 3. Effect of nanocurcumin supplementation on arsenic and fluoride induced altered hepatic biochemical variables in rats. 
Values are mean ± SEM, n = 5. Values with the same symbol within each bar are not significantly different at the 5% level 
of probability.
Figure 4. Effect of nanocurcumin supplementation on arsenic and fluoride induced altered renal biochemical variables in rats. Values 
are mean ± SEM, n = 5. Values with the same symbol within each bar are not significantly different at the 5% level of 
probability.
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elevated level of ROS and restores GSH levels in both liver 
and kidney and bring it towards the normal level. However, 
prominent protection in GPx level was observed in arsenic 
with nanocurcumin treated group while GST protection 
was more pronounced in As+ F+ NC combination group in 
liver.
3.5  Liver and Kidney Function Tests in Plasma
Table 2 shows the effect of arsenic and fluoride 
exposure with co-supplementation of nanocurcumin on 
liver and kidney function tests. Liver is an important target 
for As toxicity and the same is reflected by significant 
differences in LFT parameters (GOT, GPT) on exposure 
to arsenic as compared to control. Nanocurcumin was 
slightly effective as observed in restoration of GPT levels in 
As+NC exposed group. However, no significant change was 
observed in other parameters.
4. DISCUSSION
The present study is in continuation of earlier report 
which established the efficacy of encapsulated curcumin 
nanoparticles in arsenic toxicity16. The results clearly 
demonstrated that curcumin encapsulated in chitosan 
nanoparticles retains its antioxidant and metal-chelating 
properties. This method of delivering curcumin to the 
cells overcomes its limitation of low bioavailability, thus 
providing a method to improve its clinical efficacy.  
Elevated concentrations of naturally occurring arsenic 
(As) or fluoride (F) in drinking water is a worldwide problem 
and these two elements are recognised worldwide as the 
most serious inorganic contaminants in drinking water. 
Combined arsenic and fluoride poisoning through drinking 
water may cause either more severe or less pronounced 
toxicity. Contradictory results (synergistic or antagonistic) 
in different animal models suggest to the hypothesis that 
at low concentration fluoride ions are sufficient enough 
to react with arsenic however at high concentration the 
effects are predominantly of free fluoride ions compared 
to arsenic11. Fluoride may be able to ameliorate the toxic 
Table 2. Effect of nanocurcumin supplementation on arsenic 
and fluoride induced altered SGPT, SGOT, urea and 
Creatinine activities in blood
GPT GOT Urea Creatinine
Control 95.6±2.9* 139.1±4.1* 39.8±2.1* 0.60±0.01*As 70.3±3.5† 124.3±1.4† 36.7±3.3* 0.64±0.02†
F 75.9±6.6† 138.5±4.5* 46.3±2.8† 0.64±0.02†
As + F 76.4±2.7† 126.5±3.6† 44.2±1.6† 0.65±0.01†
As + NC 82.1±2.6† 144.9±7.0* 38.4±1.5* 0.65±0.02†
F + NC 76.5±4.3† 140.1±4.7* 43.1±2.6† 0.66±0.02†
As + F + NC 71.8±4.6† 120.8±5.9† 45.7±2.4† 0.64±0.02†
NC 90.8±1.5* 148.7±6.1* 35.5±1.9* 0.66±0.01†
Abbreviations used and units: GPT, Serum Glutamate Pyruvate 
Transaminase as Iu/L; GOT, Serum Glutamate Oxalate Transaminase as 
Iu/L; urea as mg/dl; Creatinine as mg/dl. Values are means ± SEM; n = 5. 
Differences between values with matching symbol notations within each 
bar are not statistically significant at 5% level of probability.
Figure 5. Effect of nanocurcumin supplementation on arsenic 
and fluoride induced DNA damage (8-OHdG) in rats. 
Values are mean ± SEM, n = 5. Values with the same 
symbol within each bar are not significantly different 
at the 5% level of probability.
Figure 6. Effect of nanocurcumin supplementation on arsenic 
and fluoride concentration in rat blood. Values are 
mean ± SEM, n = 5. Values with the same symbol 
within each bar are not significantly different at the 
5% level of probability.
On the other hand, kidney is considered to be an 
important target organ for fluoride toxicity. We do observed 
significant changes in plasma urea and creatinine levels 
on exposure to F. However, treatment with Nanocurcumin 
did not revealed any significant prevention which needs 
further exploration.
3.6 Urinary 8-OHdG Levels (a Biomarker of DNA 
Damage)
Figure 5 represents the effect of nanocurcumin on 
arsenic and fluoride induced DNA damage in terms of 
8-OHdG level in rats. Arsenic and fluoride significantly 
enhanced the level of 8-OHdG in the groups exposed 
with arsenic and fluoride individually and concomitantly 
although to different degrees. Nanocurcumin prevented 
DNA damage in As exposed group, however the effect was 
not observed when the two toxicants were administered 
concomitantly.
3.7 Arsenic and Fluoride Levels
A chelating effect of nanocurcumin was observed in 
blood as evidenced by significant depletion of arsenic and 
fluoride concentrations (Fig. 6).
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effects of arsenic either through strong bond with arsenic 
or may be able to decrease its affinity for active cell 
components. Decreased toxicity of arsenic and fluoride co-
exposure can be exposed on the basis of ionisation. Sodium 
fluoride is an ionic compound and gets completely ionised 
in aqueous solution. 
Apart from affecting organs like liver and kidney it 
has been shown that inflammatory responses may play a 
crucial role in the mechanism of the cardiovascular toxicity 
of arsenic and fluoride25. Reports have also indicated that 
individuals exposed to As or F or As/F show a different 
pattern of gene expression compared to non-exposed 
subjects and thus have different consequences at cellular 
and genomic levels26. Chinoy and Shah have reported altered 
histology of cerebral hemisphere following combined 
arsenic-fluoride exposure in wherein the effects produced 
by arsenic were more prominent as compared to fluoride27. 
Decreased activity of antioxidant enzymes and increased 
lipid peroxidation is also reported following combined 
arsenic and fluoride exposure. Increased activity of SOD, 
catalase and GPx and increased thiol status has also been 
reported following combined exposure to these toxicants27. 
Genotoxic effects of the combined exposure to As and F 
were reported to be more pronounced as compared to their 
individual exposure28-29.
Curcumin and its derivatives have shown the ability 
of being free-radical scavenger, interacting with oxidative 
cascade, quenching oxygen, chelating and diminishing 
oxidative properties of metal ions. It has been investigated 
in ameliorating heavy metal toxicity30-33. However, the 
major problem associated with the use of curcumin is its 
bioavailability. Recently, a lot of researches have focused on 
site specific targeted delivery of drugs using nanoparticles 
as carrier molecules. Efficacy of drugs can be enhanced 
by targeting the drugs through nanoparticles as carriers. 
These particles have easy accessibility in the body due to 
its smaller particle size and can be transported to different 
body sites through blood circulation. 
Co-administration of nanocurcumin with arsenic and 
fluoride resulted in lowering of reactive oxygen species and 
restoration of blood glutathione level which were found 
to be altered in arsenic and fluoride intoxicated groups. 
Nanocurcumin also found to be effective in reversing 
δ-aminolevulinic acid dehydratase (ALAD) inhibition 
caused by arsenic exposure. This could be attributed to the 
availability of sulfhydryl group and antioxidant effects of 
curcumin. Several studies established the ability of curcumin 
to inhibit the generation of the superoxide radicals34 by 
the increased production of GSH, which is a major non 
protein thiol in living organisms and plays a crucial role 
in co-coordinating the body’s antioxidant defence process. 
In agreement to the above argument curcumin has been 
shown to reduce the induction in the levels of ROS and 
increase the activities of antioxidant enzymes and the levels 
of SH-groups in vivo, when co administered with arsenic. 
Thus, curcumin administration may reduce oxidative stress 
thereby being beneficial against toxic effects of arsenic and 
fluoride by reducing oxidative stress35. 
Co-administration of nanocurcumin was proved to 
be effective in the recovery of altered ROS and TBARS 
levels, followed by improved GSH level, and GPx and GST 
activities in rat liver and kidney both. It may be illustrious 
that curcumin counteracts the arsenic and fluoride 
induced tissue damage by quenching the generation of 
ROS. Due to the presence of polyphenolic structure and 
a β-diketone functional group curcumin has stronger 
antioxidant inhibitor properties than other flavonoids 
having single phenolic hydroxyl group. Our data proved 
that administration of arsenic and fluoride creates free 
radicals, which in turn alter the antioxidant systems, 
and necessarily lead to an increased lipid peroxidation. 
Nevertheless, co-supplementation of nanocurcumin 
along with these toxicants led to a significant decrease in 
lipid peroxidation and increased antioxidant activity. Our 
observation confirms the earlier finding which shows that 
administration of curcumin decreases the level of TBARS 
by improving the antioxidant status which is attributed to 
the longer circulation time of the nanoparticle in the blood 
which increases its bioavailability and hence the efficacy.
Earlier reports have demonstrated the efficacy of 
curcumin to chelate out heavy metals from the brain30-31 
as well as from liver and kidney32 at a dose of ~100 mg/
kg body weight curcumin which is quite high. Although, 
the ameliorating effect of curcumin on sodium arsenite-
induced oxidative damage and lipid peroxidation in 
different rat organs have also been shown at a lower dose 
of 15 mg/kg35-36 but the data lacked any information on the 
metal content. The most promising result from our study 
shows that curcumin encapsulated chitosan nanoparticles 
at a dose of 15 mg/kg removes not only arsenic but also 
fluoride from blood which is due to the chelating potential 
of nanocurcumin. This can be attributed to the unique 
property of the chitosan nanoparticle which has longer 
circulation time in blood and helps in a sustained release of 
curcumin. Nano-encapsulation of curcumin may allow drug 
circulation and retention in the body thus not only reducing 
the dose but also maintaining its threshold bioavailability.
Thus in light of the present information, we conclude 
nanocurcumin successfully ameliorates the toxic effects of 
arsenic and fluoride in rat blood and tissues. The results also 
recorded the enhanced antioxidant and chelating potential 
of curcumin encapsulated chitosan nanoparticles at a much 
lower dose as a treatment regimen for both arsenic and 
fluoride toxicity. The results from our study have added a 
new dimension in the treatment of metal poisoning. We 
also hypothesise that a combination drug delivery therapy 
employing two nanosystems- a chelator and a strong anti-
oxidant may produce synergistic effects in the treatment of 
arsenic and/or fluoride toxicity. We plan to investigate the 
same in our future studies to get into an insight into the 
mechanistic picture and provide answers to some of our 
unanswered experimental observations.     
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